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LETTER TO THE EDITOR
Cancer in the offspring of survivors of childhood leukaemia and non-
Hodgkin lymphomas
Sir - In their recent paper, Hawkins et al. (Br. J. Cancer,
(1995), 71, 1335-1339) conclude that inherited abnormal
alleles do not appear to be important in the aetiology of
childhood leukaemia. This is clearly an important contribu-
tion to the debate about the heritability of leukaemia, the
role of spontaneous and radiation-induced germline mutation
and the long-term effects of therapy on the risks to offspring.
Their conclusions are based on an analysis of cancer in the
offspring of survivors ofchildhood leukaemia and NHL born
between 1940 and 1969. They obtained data on 382 offspring
of 737 leukaemiafNHL survivors with a median follow-up
period of 5.8 years, and they calculate that the risk of cancer
is not likely to be greater than 8-fold above that expected for
the population as a whole. In fact, they conclude that there is
no evidence of increased risk of cancer to the offspring of
leukaemia/NHL survivors.
The small number ofsurvivors and offspring studied must,
however, raise doubts about this conclusion. Hawkins et al.
acknowledge that detailed estimates of the heritability (of
abnormal alleles) depend upon a number of unverified
assumptions, and they suggest that a degree of caution is
necessary. More important than this, their paper lacks detail
that might have enabled the reader to put their conclusions
into perspective. Although they state that 5227 children with
cancer were still alive, they do not give a figure for the total
number of cases in the study period. If we use their estimate
of 1200 newly diagnosed childhood cancers in Britain per
year, this would mean that about 34800 cancers and
leukaemias were diagnosed between 1940 and 1969, which
indicates that only 15% of cases survived. Assuming that the
proportion of childhood leukaemias was about 30% and
NHL about 7% of total cancers (Stiller et al., 1991), about
12876 of the 34800 children would have had one of these
two diseases. This means that the 885 survivors of leukaemia
and NHL and the 737 actual respondents to the study
constitute only about 6.8% and 5.7% respectively of all
children diagnosed with leukaemia and NHL during the
study period. This is a very small proportion on which to
base conclusions about the overall heritability of leukaemia
and NHL. Most of the leukaemia/NHL survivors with
offspring would presumably have been diagnosed in the
latter part of the study period, when survival rates would
have been appreciably higher than in the 1940s and 1950s,
but again this information is lacking. The potential for bias
and selectivity for non-heritable cases is significant.
Hawkins et al. base their heritability calculations of
recurrence risk in offspring on autosomal dominant
inheritance with a penetrance of 0.7. It is highly improbable
that any heritability in leukaemia and NHL, except in rare
familial cases, follows this pattern. Even in the predisposing
genetic disorders with a high risk of leukaemia, which are
nearly all recessive, penetrance does not reach this level
(Taylor and Birch, 1995). There is clearly a need to monitor
the long-term health ofthe children of survivors ofchildhood
cancer and leukaemia, but the use of historical and
potentially biased data to draw overall conclusions about
the heritability of leukaemia and NHL, about the germline
effects of radiation, and for the purposes of genetic
counselling could be potentially misleading.
G Malcolm Taylor
Immunogenetics Laboratory,
St Marys Hospital, Manchester, UK
References
HAWKINSMM, DRAPERGJANDWINTERDL. (1995). Cancerin the
offspring ofsurvivors ofchildhood leukaemia and non-Hodgkin's
lymphomas. Br. J. Cancer, 71, 1335-1339.
STILLERCA, MCKINNEYPA, BUNCH KJ, BAILEY CC AND LEWIS U.
(1991). Childhood cancer and ethnic group in Britain: a United
Kindgom Children's Cancer Study Group (UKCCSG) study. Br.
J. Cancer, 64, 543-548.
TAYLORGM AND BIRCH JM. (1995). The hereditary basis ofhuman
leukaemia, In Leukemia, Henderson ES, Lister TA and Greaves
MF (eds). Chapter 12.WB Saunders: Cambridge, MA, USA (in
press).